A 68-year-old retired teacher is admitted to the cardiac telemetry unit for the elective initiation of dofetilide to maintain normal sinus rhythm after a recent electrical cardioversion for symptomatic atrial fibrillation. He has a history of hypertension and ischemic cardiomyopathy. His home medications include lisinopril, metoprolol succinate, and apixaban. His vital signs are stable, and the physical examination is unremarkable. The care team is planning the mandatory safety protocol for initiating this antiarrhythmic therapy.
Arrange the following clinical steps in the correct chronological sequence for the initiation, monitoring, and evaluation of dofetilide therapy in this patient.
- 1Calculate baseline creatinine clearance and obtain a 12-lead ECG to measure the QTc interval.
- 2Administer the first dose of the antiarrhythmic agent based on the patient's renal function.
- 3Perform a follow-up 12-lead ECG 2 to 3 hours after the initial dose.
- 4Reduce the subsequent dose if the QTc interval increases by more than 15% from baseline or exceeds 500 ms.
- 5Continue in-hospital telemetry monitoring for a minimum of 3 days (6 doses) before discharge.
Answer
The correct chronological sequence is to first establish baseline parameters, administer the initial dose, perform peak ECG monitoring at 2 to 3 hours, adjust the dose if QTc prolongation is observed, and finally complete the mandatory 3-day inpatient monitoring period.
The initiation of dofetilide requires mandatory in-hospital monitoring due to its profound risk of dose-dependent QT prolongation and torsades de pointes. The standard protocol requires obtaining a baseline ECG and renal function to calculate the starting dose, as the drug is renally cleared. After the first dose is administered, the peak effect occurs at 2 to 3 hours, mandating an ECG at this exact time to evaluate repolarization changes. If the QTc interval increases by >15% or exceeds 500 ms at peak, a protocolized dose reduction is required. Finally, because steady-state and peak risks stabilize over several days, the patient must remain on continuous telemetry for a minimum of 3 days or 6 doses (whichever is greater) before safe transition to outpatient management.
Step-by-Step Solution
Key Concept
The initiation of dofetilide requires a strict inpatient protocol consisting of baseline assessment, renal dosing, peak ECG monitoring at 2-3 hours post-dose to evaluate for repolarization abnormalities, algorithmic dose adjustment, and a mandatory minimum 3-day telemetry monitoring period.